These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24252280)

  • 1. Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins.
    Piubelli L; Campa M; Temporini C; Binda E; Mangione F; Amicosante M; Terreni M; Marinelli F; Pollegioni L
    Microb Cell Fact; 2013 Nov; 12():115. PubMed ID: 24252280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of multiple TB antigens TB10.4 and TB10.4-Ag85B as subunit vaccine candidates against Mycobacterium tuberculosis.
    Shi S; Yu L; Sun D; Liu J; Hickey AJ
    Pharm Res; 2010 Feb; 27(2):224-34. PubMed ID: 19862606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prokaryotic expression and immunological characteristics of Mycobacterium tuberculosis Rv1886c].
    Tao C; Zhao D; Dong H; Shan F; Lian K; Pan Z; Chen X; Yin Y; Jiao X
    Wei Sheng Wu Xue Bao; 2014 Mar; 54(3):330-7. PubMed ID: 24984525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against
    Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C
    J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the genetic diversity of Mycobacterium tuberculosis esxA, esxH, and fbpB genes among clinical isolates and its implication for the future immunization by new tuberculosis subunit vaccines Ag85B-ESAT-6 and Ag85B-TB10.4.
    Davila J; Zhang L; Marrs CF; Durmaz R; Yang Z
    J Biomed Biotechnol; 2010; 2010():208371. PubMed ID: 20617139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
    Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylation of Recombinant Antigenic Proteins from Mycobacterium tuberculosis: In Silico Prediction of Protein Epitopes and Ex Vivo Biological Evaluation of New Semi-Synthetic Glycoconjugates.
    Bavaro T; Tengattini S; Piubelli L; Mangione F; Bernardini R; Monzillo V; Calarota S; Marone P; Amicosante M; Pollegioni L; Temporini C; Terreni M
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28661444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy.
    Dietrich J; Aagaard C; Leah R; Olsen AW; Stryhn A; Doherty TM; Andersen P
    J Immunol; 2005 May; 174(10):6332-9. PubMed ID: 15879133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a modified vector for efficient purification of recombinant Mycobacterium tuberculosis proteins expressed in Escherichia coli.
    Ahmad S; Ali MM; Mustafa AS
    Protein Expr Purif; 2003 Jun; 29(2):167-75. PubMed ID: 12767806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of TAT-Ag85B protein vaccine and evaluation of its anti-Myobacterium tuberculosis effect].
    Zhang R; Wang W; Hu D; Wang W; Xing Y; He J; Dai J; Wu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):49-53. PubMed ID: 25575059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens.
    Skjøt RL; Oettinger T; Rosenkrands I; Ravn P; Brock I; Jacobsen S; Andersen P
    Infect Immun; 2000 Jan; 68(1):214-20. PubMed ID: 10603390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative approach to strategies for cloning, expression, and purification of Mycobacterium tuberculosis mycolyl transferase 85B and evaluation of immune responses in BALB/c mice.
    Aghababa H; Mohabati Mobarez A; Khoramabadi N; Behmanesh M; Mahdavi M; Tebianian M; Nejati M
    Mol Biotechnol; 2014 Jun; 56(6):487-97. PubMed ID: 24619477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70.
    Tebianian M; Hoseini AZ; Ebrahimi SM; Memarnejadian A; Mokarram AR; Mahdavi M; Sohrabi N; Taghizadeh M
    Biologicals; 2011 May; 39(3):143-8. PubMed ID: 21388826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological memory transferred with CD4 T cells specific for tuberculosis antigens Ag85B-TB10.4: persisting antigen enhances protection.
    Duffy D; Dawoodji A; Agger EM; Andersen P; Westermann J; Bell EB
    PLoS One; 2009 Dec; 4(12):e8272. PubMed ID: 20011592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.
    Aagaard C; Hoang TT; Izzo A; Billeskov R; Troudt J; Arnett K; Keyser A; Elvang T; Andersen P; Dietrich J
    PLoS One; 2009 Jun; 4(6):e5930. PubMed ID: 19529771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A standardized production pipeline for high profile targets from Mycobacterium tuberculosis.
    Milewski MC; Broger T; Kirkpatrick J; Filomena A; Komadina D; Schneiderhan-Marra N; Wilmanns M; Parret AH
    Proteomics Clin Appl; 2016 Oct; 10(9-10):1049-1057. PubMed ID: 27400835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced anti-tuberculosis immunity by a TAT-Ag85B protein vaccine in a murine tuberculosis model.
    Dong H; Jing W; Yingru X; Wenyang W; Ru C; Shengfa N; Congjing X; Jingjing D; Wan W; Jiang H; Rongbo Z
    Pathog Glob Health; 2015; 109(8):363-8. PubMed ID: 26924346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced immune response and protection efficacy of a DNA vaccine constructed by linkage of the Mycobacterium tuberculosis Ag85B-encoding gene with the BVP22-encoding gene.
    Yao W; Liu S; Qu X; Xiao S; Liu Y; Liu J
    J Med Microbiol; 2009 Apr; 58(Pt 4):462-468. PubMed ID: 19273642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral immunogenicity of recombinant Mycobacterium smegmatis expressing Ag85B epitopes in mice.
    Kadir NA; Sarmiento ME; Acosta A; Norazmi MN
    Int J Mycobacteriol; 2016 Mar; 5(1):7-13. PubMed ID: 26927984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.